Tandem Diabetes Care (TNDM) legal chief reports RSU vesting, tax withholding and ESPP purchase
Shannon M. Hansen, EVP & Chief Legal Officer at Tandem Diabetes Care (TNDM), reported routine equity compensation activities. These included the exercise of 10,201 restricted stock units (RSUs), with 5,192 shares withheld for tax obligations, and the purchase of 1,886 shares through the Employee Stock Purchase Plan (ESPP) at $10.90 per share. Following these transactions, Hansen directly holds 28,285 shares and indirectly holds 1,935 shares.
MAY 8·BioSpace▲
Tandem Diabetes Care Announces First Quarter 2026 Financial Results
Tandem Diabetes Care (Nasdaq: TNDM) reported strong Q1 2026 financial results, achieving record pump shipments and sales, along with a significant increase in gross margin. The company reaffirmed its full-year 2026 financial guidance and highlighted strategic advancements like the launch of a new reimbursement model and expanded Android compatibility for its Tandem Mobi system. These results demonstrate Tandem's commitment to innovation and growth in the diabetes technology market.
MAY 1·Stock Titan→
Vanguard Capital Management files 13G for Tandem Diabetes Care (NYSE: TNDM) — 3.55M shares
Vanguard Capital Management has filed a Schedule 13G for Tandem Diabetes Care (NYSE: TNDM), reporting beneficial ownership of 3,553,772 shares, which represents a 5.18% stake in the company. The filing indicates that Vanguard has sole dispositive power over all these shares and sole voting power over 514,853 shares, signaling a significant, passive institutional investment. This disclosure provides transparency regarding Vanguard's substantial holding in Tandem Diabetes Care.
